Pedraza Neus, Rosell Meritxell, Villarroya Joan, Iglesias Roser, Gonzalez Frank J, Solanes Gemma, Villarroya Francesc
Departament de Bioquímica i Biologia Molecular, Universitat de Barcelona, Avda Diagonal 645, E-08028 Barcelona, Spain.
Endocrinology. 2006 Oct;147(10):4695-704. doi: 10.1210/en.2006-0226. Epub 2006 Jul 20.
Uncoupling protein-3 (UCP3) is a member of the mitochondrial carrier family expressed preferentially in skeletal muscle and heart. It appears to be involved in metabolic handling of fatty acids in a way that minimizes excessive production of reactive oxygen species. Fatty acids are powerful regulators of UCP3 gene transcription. We have found that the role of peroxisome proliferator-activated receptor-alpha (PPARalpha) on the control of UCP3 gene expression depends on the tissue and developmental stage. In adults, UCP3 mRNA expression is unaltered in skeletal muscle from PPARalpha-null mice both in basal conditions and under the stimulus of starvation. In contrast, UCP3 mRNA is down-regulated in adult heart both in fed and fasted PPARalpha-null mice. This occurs despite the increased levels of free fatty acids caused by fasting in PPARalpha-null mice. In neonates, PPARalpha-null mice show impaired UCP3 mRNA expression in skeletal muscle in response to milk intake, and this is not a result of reduced free fatty acid levels. The murine UCP3 promoter is activated by fatty acids through either PPARalpha or PPARdelta but not by PPARgamma or retinoid X receptor alone. PPARdelta-dependent activation could be a potential compensatory mechanism to ensure appropriate expression of UCP3 gene in adult skeletal muscle in the absence of PPARalpha. However, among transcripts from other PPARalpha and PPARdelta target genes, only those acutely induced by milk intake in wild-type neonates were altered in muscle or heart from PPARalpha-null neonates. Thus, PPARalpha-dependent regulation is required for appropriate gene regulation of UCP3 as part of the subset of fatty-acid-responsive genes in neonatal muscle and heart.
解偶联蛋白3(UCP3)是线粒体载体家族的成员,在骨骼肌和心脏中优先表达。它似乎以一种尽量减少活性氧过量产生的方式参与脂肪酸的代谢处理。脂肪酸是UCP3基因转录的有力调节因子。我们发现,过氧化物酶体增殖物激活受体α(PPARα)对UCP3基因表达的控制作用取决于组织和发育阶段。在成年动物中,无论是在基础条件下还是在饥饿刺激下,PPARα基因敲除小鼠骨骼肌中的UCP3 mRNA表达均未改变。相比之下,在喂食和禁食的PPARα基因敲除小鼠的成年心脏中,UCP3 mRNA均下调。尽管PPARα基因敲除小鼠禁食导致游离脂肪酸水平升高,但仍出现这种情况。在新生儿中,PPARα基因敲除小鼠对乳汁摄入的反应是骨骼肌中UCP3 mRNA表达受损,这不是游离脂肪酸水平降低的结果。小鼠UCP3启动子可被脂肪酸通过PPARα或PPARδ激活,但不能被单独的PPARγ或视黄酸X受体激活。PPARδ依赖性激活可能是一种潜在的补偿机制,以确保在没有PPARα的情况下成年骨骼肌中UCP3基因的适当表达。然而,在其他PPARα和PPARδ靶基因的转录本中,只有那些在野生型新生儿中由乳汁摄入急性诱导的转录本在PPARα基因敲除新生儿的肌肉或心脏中发生了改变。因此,作为新生儿肌肉和心脏中脂肪酸反应性基因子集的一部分,UCP3的适当基因调控需要PPARα依赖性调节。